Kenvue (NYSE:KVUE) Updates FY 2025 Earnings Guidance

Kenvue (NYSE:KVUE) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 1.440-1.469 for the period, compared to the consensus earnings per share estimate of 1.250. The company issued revenue guidance of $15.3 billion-$15.6 billion, compared to the consensus revenue estimate of $15.9 billion.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on KVUE. Barclays dropped their target price on shares of Kenvue from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. JPMorgan Chase & Co. increased their target price on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. UBS Group dropped their target price on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $24.00 target price on shares of Kenvue in a research report on Monday. Finally, Bank of America raised their price objective on shares of Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $23.00.

Kenvue Stock Performance

Shares of KVUE stock traded up $0.30 during mid-day trading on Friday, hitting $20.10. The stock had a trading volume of 10,853,820 shares, compared to its average volume of 12,488,188. Kenvue has a fifty-two week low of $17.67 and a fifty-two week high of $24.46. The firm has a market cap of $38.53 billion, a PE ratio of 36.55, a PEG ratio of 2.05 and a beta of 1.45. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The company’s 50-day simple moving average is $21.61 and its 200-day simple moving average is $21.93.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, hitting the consensus estimate of $0.26. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. Sell-side analysts anticipate that Kenvue will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be paid a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 4.08%. The ex-dividend date is Wednesday, February 12th. Kenvue’s dividend payout ratio (DPR) is 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.